Molecular Targeting Technologies, Inc. and Molecular Theranostics Center of Singapore Receive HSA Approval for Clinical Trial Authorization for EBTATE® in Nasopharyngeal Cancer
WEST CHESTER, Pa. & SINGAPORE--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), and its wholly owned subsidiary,…